BeStock  
Stocks › Biotechnology › AURA

Aura Biosciences AURA

US equityMarket cap rank #3369Biotechnology
$6.87 −$0.11 (-1.58%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $6.77 -1.46%
Open$6.51
Prev close$6.98
Day range$6.51 – $6.98
Volume791.1K
Market cap$714.99M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership96.1%+2.64 pts vs. prior quarter
Institutions holding186+6 vs. prior quarter
Insider trades (recent)36 buys / 14 sellsNet buying
Short interest10.09% of floatDays to cover 13.7 · as of 30 Oct 2026
Short-sale volume share22.5%5-day average of daily volume

Short-sale volume as % of daily volume

13%21%28%36%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$1.61M (7 inflow days, 13 outflow days).

Net flow by order size, last 20 sessions

−$1.7MSuper+$82.1KBig+$404.4KMid+$52.2KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 31.9% of shares outstanding.

Largest holders

  • TCG Crossover Management, LLC9.16%
  • Montanova Capital, LLC6.92%
  • Frazier Life Sciences Management, LP5.60%
  • BlackRock5.21%
  • Forbion Capital Partners B.V.5.04%
  • Long Focus Capital Management LLC4.92%
  • Adage Capital Management, L.P.4.46%
  • Caligan Partners, LP4.13%

By investor type

  • Hedge Fund35.63%
  • VC/PE Fund33.70%
  • Mutual Fund25.48%
  • Individual/Insider1.20%
  • Public Company0.83%
  • Private Company0.30%
  • Insurance Company0.08%
  • Family Office/Trust0.06%

Reported short interest has risen from 5.94% to 10.09% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
State Street Global Advisors Mutual Fund 2026/Q3 +1,078,536 2.2%
BlackRock Mutual Fund 2026/Q3 +716,590 5.2%
Forbion Capital Partners B.V. VC/PE Fund 2026/Q3 +1,195,066 5.0%
TCG Crossover Management, LLC VC/PE Fund 2026/Q3 +9,533,333 9.2%
Caligan Partners, LP Hedge Fund 2026/Q3 +4,068,384 4.1%
OrbiMed Advisors LLC VC/PE Fund 2026/Q3 +3,333,333 3.2%
Montanova Capital, LLC Hedge Fund 2026/Q3 +2,833,333 6.9%
RA Capital Management, L.P. VC/PE Fund 2026/Q3 +2,500,000 2.4%
Janus Henderson Group plc Mutual Fund 2026/Q3 +2,500,000 2.4%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +2,096,558 4.6%
Balyasny Asset Management L.P. Hedge Fund 2026/Q3 +1,796,965 2.3%
Redmile Group, LLC Hedge Fund 2026/Q3 +1,666,667 1.6%
EcoR1 Capital, LLC Hedge Fund 2026/Q3 +1,666,667 1.6%
Trails Edge Capital Partners, LP Hedge Fund 2026/Q3 +1,443,333 1.4%
Foresite Capital Management, LLC VC/PE Fund 2026/Q3 +1,333,334 1.3%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
31 Aug 2026 Julie Person Chief Human Resources Officer Other Acquisition +107,611 – 107,611
31 Aug 2026 Julie Person Chief Human Resources Officer Other Derivative Acquisition +212,389 $7.43 212,389
31 Aug 2026 Susan Abu-Absi Chief Operating Officer Other Acquisition +134,513 – 134,513
31 Aug 2026 Susan Abu-Absi Chief Operating Officer Other Derivative Acquisition +265,487 $7.43 265,487
31 Aug 2026 Erica Kratz Chief Regulatory & Quality Officer Other Acquisition +100,885 – 100,885
31 Aug 2026 Erica Kratz Chief Regulatory & Quality Officer Other Derivative Acquisition +199,115 $7.43 199,115
31 Aug 2026 J. Hopkins Chief Medical Officer & President of Research and Development Other Acquisition +58,850 – 60,050
31 Aug 2026 J. Hopkins Chief Medical Officer & President of Research and Development Other Derivative Acquisition +116,150 $7.43 116,150
31 Aug 2026 Amy Elazzouzi Senior Vice President of Finance, Treasurer and Secretary Other Acquisition +23,540 – 143,600
31 Aug 2026 Amy Elazzouzi Senior Vice President of Finance, Treasurer and Secretary Other Derivative Acquisition +46,460 $7.43 46,460
6 Jul 2026 Jeremy Bender Independent Director Other Acquisition +30,000 – 30,000
6 Jul 2026 Jeremy Bender Independent Director Other Derivative Acquisition +60,000 $7.03 60,000
30 Jun 2026 Conor Kilroy Former Chief Legal Officer Other Acquisition +14,858 – 193,053
15 Jun 2026 Anthony Gibney Former Chief Financial & Business Officer Open Market Disposition -12,824 $6.42 81,609
10 Jun 2026 Sapna Srivastava Independent Director Other Acquisition +15,000 – 15,000
10 Jun 2026 Sapna Srivastava Independent Director Other Derivative Acquisition +30,000 $6.21 30,000
10 Jun 2026 Antony Mattessich Independent Director Other Acquisition +15,000 – 15,000
10 Jun 2026 Antony Mattessich Independent Director Other Derivative Acquisition +30,000 $6.21 30,000
10 Jun 2026 David Johnson Independent Chairperson Other Acquisition +15,000 – 15,000
10 Jun 2026 David Johnson Independent Chairperson Other Derivative Acquisition +30,000 $6.21 30,000

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 10,464,215 10.1% 13.7
15 Oct 2026 10,885,962 10.5% 10.6
30 Sep 2026 10,366,122 10.0% 9.2
15 Sep 2026 7,049,973 6.8% 11.7
31 Aug 2026 6,203,498 6.0% 6.4
14 Aug 2026 6,158,945 5.9% 9.9

Discussion

No comments yet — be the first to weigh in on AURA.

Sign in to join the discussion.

Scroll to Top